Skip to main content
. 2022 Oct 7;10:1024143. doi: 10.3389/fbioe.2022.1024143

FIGURE 5.

FIGURE 5

Targeted survivin regulation by the DNA-dendrimer-based nanomedicine D4‒3-As-DzSur. (A) Biotechnological production. (B) 2D structure. (C) Cryo-TEM image. (D) Survivin mRNA cleavage property. (E) qPCR tests. (F) Western blot analysis of survivin suppression in A549 cells. (G) Apoptosis analysis of A549 cell. (H,I) Chemosensitization effect on DOX (H) and paclitaxel (I). (Lu et al., 2021).